X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (5) 5
female (4) 4
humans (4) 4
index medicus (4) 4
obstetrics & gynecology (4) 4
ovarian cancer (4) 4
aged (3) 3
chemotherapy (3) 3
cisplatin (3) 3
adult (2) 2
analysis (2) 2
antineoplastic agents - therapeutic use (2) 2
cancer (2) 2
carcinoma (2) 2
cohort studies (2) 2
hematology, oncology and palliative medicine (2) 2
middle aged (2) 2
obstetrics and gynecology (2) 2
ovarian neoplasms - drug therapy (2) 2
ovarian neoplasms - genetics (2) 2
paclitaxel (2) 2
trial (2) 2
adenocarcinoma, clear cell - drug therapy (1) 1
adenocarcinoma, clear cell - metabolism (1) 1
adenocarcinoma, clear cell - pathology (1) 1
admission (1) 1
adverse outcomes (1) 1
african americans (1) 1
african americans - genetics (1) 1
antibody (1) 1
antinematodal agents - therapeutic use (1) 1
antineoplastic agents - economics (1) 1
antineoplastic combined chemotherapy protocols - economics (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor-activity (1) 1
article (1) 1
ascites - drug therapy (1) 1
ascites - metabolism (1) 1
ascites - pathology (1) 1
beta catenin - metabolism (1) 1
black-women (1) 1
blotting, western (1) 1
brca (1) 1
brca mutations (1) 1
breast-cancer (1) 1
cancer patients (1) 1
cancer stem cells (1) 1
carboplatin (1) 1
carboplatin - administration & dosage (1) 1
carboplatin - economics (1) 1
carboplatin - therapeutic use (1) 1
care and treatment (1) 1
cell survival - drug effects (1) 1
cells (1) 1
chemoresistance (1) 1
combination (1) 1
cost benefit analysis (1) 1
cost-benefit analysis (1) 1
cost-effectiveness (1) 1
cystadenocarcinoma, serous - drug therapy (1) 1
cystadenocarcinoma, serous - metabolism (1) 1
cystadenocarcinoma, serous - pathology (1) 1
decision support techniques (1) 1
disease-free survival (1) 1
diseases (1) 1
docetaxel (1) 1
dosage and administration (1) 1
drug therapy, combination (1) 1
early warning score (1) 1
endometrial neoplasms - drug therapy (1) 1
endometrial neoplasms - metabolism (1) 1
endometrial neoplasms - pathology (1) 1
epithelial (1) 1
epithelial ovarian (1) 1
epithelial ovarian cancer (1) 1
genes, brca1 (1) 1
genes, brca2 (1) 1
genetic counseling (1) 1
genetic predisposition (1) 1
genetic predisposition to disease (1) 1
genetic testing (1) 1
genital neoplasms, female - surgery (1) 1
germ-line mutation (1) 1
gynecologic-oncology-group (1) 1
health aspects (1) 1
health disparities (1) 1
hereditary breast (1) 1
hysterectomy (1) 1
intensive-care-unit (1) 1
intraperitoneal chemotherapy (1) 1
laparoscopic surgery (1) 1
laparoscopy (1) 1
laparotomy (1) 1
learning curve (1) 1
length of stay (1) 1
lrp6 (1) 1
maintenance chemotherapy - economics (1) 1
maintenance chemotherapy - methods (1) 1
medical history taking (1) 1
medicine & public health (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of clinical oncology, ISSN 0277-3732, 01/2019, Volume 42, Issue 1, pp. 12 - 16
Objective: The objective of this study was to report the tolerability and toxicity of a regimen consisting of intravenous (IV) docetaxel and intraperitoneal... 
docetaxel | ovarian cancer | intraperitoneal chemotherapy | TRIAL | CARBOPLATIN | STAGE-III OVARIAN | CISPLATIN | ONCOLOGY | SAFETY | EPITHELIAL OVARIAN | PACLITAXEL | Chemotherapy | Usage | Care and treatment | Cancer patients | Docetaxel | Dosage and administration | Research | Health aspects | Cisplatin | Ovarian cancer | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 4677 - 4677
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 139, Issue 1, pp. 59 - 62
Abstract Purpose To determine the cost-effectiveness of olaparib, a PARP inhibitor, as maintenance therapy for platinum-sensitive (PS) recurrent ovarian... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | BRCA | PARP inhibitiors | Olaparib | Cost-effectiveness | Ovarian cancer | GYNECOLOGIC-ONCOLOGY-GROUP | STAGE-III | CHEMOTHERAPY | PACLITAXEL | OBSTETRICS & GYNECOLOGY | TRIAL | WOMEN | CISPLATIN | ONCOLOGY | Neoplasm Recurrence, Local - economics | United States | Humans | Neoplasm Recurrence, Local - drug therapy | Piperazines - economics | Phthalazines - economics | Antineoplastic Agents - therapeutic use | Models, Economic | Ovarian Neoplasms - genetics | Maintenance Chemotherapy - methods | Antineoplastic Combined Chemotherapy Protocols - economics | Genes, BRCA2 | Germ-Line Mutation | Female | Genes, BRCA1 | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Paclitaxel - economics | Decision Support Techniques | Carboplatin - administration & dosage | Piperazines - therapeutic use | Carboplatin - economics | Antineoplastic Agents - economics | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Disease-Free Survival | Poly(ADP-ribose) Polymerase Inhibitors - economics | Phthalazines - therapeutic use | Ovarian Neoplasms - economics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cost-Benefit Analysis | Maintenance Chemotherapy - economics | Neoplasm Recurrence, Local - genetics | Relapse | Cost benefit analysis | Analysis | Diseases
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 10/2015, Volume 25, Issue 8, pp. 1377 - 1385
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 2517 - 2517
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2015, Volume 21, Issue 16 Supplement, pp. POSTER-THER-1402 - POSTER-THER-1402
Journal Article
世界干细胞杂志:英文版(电子版), ISSN 1948-0210, 2014, Volume 6, Issue 4, pp. 441 - 447
Despite significant effort and research funds, epithelial ovarian cancer remains a very deadly disease. There are no effective screening methods that discover... 
Targeted | Chemotherapy | cells | ovarian | therapy | Chemoresistance | cancer | Recurrent | Epithelial | stem | Epithelial ovarian cancer | Targeted therapy | Recurrent ovarian cancer | Minireviews | Cancer stem cells
Journal Article
Journal of Robotic Surgery, ISSN 1863-2483, 9/2014, Volume 8, Issue 3, pp. 207 - 211
This study evaluated intraoperative complications and postoperative outcomes of gynecologic oncology patients undergoing robotic-assisted (RA) laparoscopic... 
Medicine & Public Health | Urology/Andrology | Learning curve | Surgery | Minimally Invasive Surgery | Robotic hysterectomy | Robotic hysterectomy complications | Laparoscopic surgery | Laparoscopy | Universities and colleges | Hysterectomy
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.